Bristol-Myers Squibb BMY Preferred Stock, Shares Outstanding
Preferred Stock, Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Bristol-Myers Squibb’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's preferred stock, shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's preferred stock, shares outstanding?
- Bristol-Myers Squibb (BMY) reported preferred stock, shares outstanding of 2.5K in Q4 2025.
- What is the long-term trend for Bristol-Myers Squibb's preferred stock, shares outstanding?
- Over 3 years (2020 to 2025), Bristol-Myers Squibb's preferred stock, shares outstanding has grown at a -10.4% compound annual growth rate (CAGR), from 3.5K to 2.5K.
- What does preferred stock, shares outstanding mean?
- The total number of preferred stock shares currently held by investors.
- How do you interpret preferred stock, shares outstanding?
- An increase indicates the issuance of new preferred equity, while a decrease signals share repurchases or conversions into common stock.
- How does preferred stock, shares outstanding compare across companies?
- Most large-cap pharmaceutical companies have simplified capital structures, so this is often zero or very low compared to common share counts.